Post-earnings recap
Reported
Thu, Feb 25, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Denali Therapeutics reported a strong earnings surprise with an EPS of $1.91, significantly exceeding expectations. However, the stock fell by 5.63% in reaction, which may indicate investor concerns or profit-taking despite the positive EPS result. The lack of revenue data and guidance may have contributed to the stock's decline.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.91 | N/A | +445.39% |
| Revenue | — | N/A | — |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.